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Abstract 
 
The objective of the proposed study is to develop new materials and methods to 
manage microbial growth in chronic wounds using phototherapy.  Chronic wounds are 
considered as a worldwide health problem. The most common chronic wounds can be 
classified into three categories: venous ulcers, diabetic ulcers, and pressure ulcers. 
Venous ulcers, which usually occur in the legs, account for about 70% to 90% of chronic 
wounds and can become infected easily. Venous ulcers are sores that develop after 
veins in the legs have been damaged. These ulcers can penetrate deeply into the skin. 
Occasionally, if a venous ulcer persists for a long time, skin cancer might develop at the 
edge.  It has been shown that several bacteria species can colonize chronic wounds as 
highly persistent biofilm communities. Chronic wound pathogenic biofilms are host-
pathogen environments that colonize and exist as a cohabitation of many bacterial 
species that cooperate to promote their own survival and the chronic nature of the 
infection. Bacterial biofilms are highly organised microbial communities living within a 
protective extracellular matrix. They are difficult to detect and highly resistant to immune 
or antibiotic elimination. There are specific major populations of bacteria that are evident 
in the biofilms of all chronic wound types. Species including Staphylococcus, 
Pseudomonas, Peptoniphilus, Enterobacter, Stenotrophomonas, Finegoldia, and 
Serratia spp are found to be common chronic wound pathogens.  
Our preliminary studies have shown that non-toxic vitamins such as riboflavin 
(vitamin B2) and cobalamin (vitamin B12) can produce singlet oxygen and free radicals 
upon irradiation. Furthermore, our data has shown, upon irradiation with low energy 
visible light, riboflavin and cobalamin both can cleave and damage native double-
stranded DNA. It is very important to use low energy visible light in the process owing to 
it penetrates human tissue much deeper then the high energy UV light. Also, visible light 
will not damage normal human cells like UV light. The delivery of visible light is a 
localized process normally using laser light transported by optical fibers. We have the 
knowledge and technology to discover and develop the drugs as well as design a 
portable laser system for PACT that can be patented and eventually commercialized. 
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Introduction 
 The objective of this invention is to use photoactive vitamin nanoparticles as new 
photodynamic antimicrobial chemotherapeutic agents to heal chronic wounds. Chronic 
wounds are considered as a worldwide health problem due to the treatment being often 
inadequate. Incorrect diagnosis, overuse of systemic antibiotics and inadequate use of 
compression therapy frequently aggravate the complications.  
 It has been shown that several bacteria species can colonize chronic wounds as 
highly persistent biofilm communities. Chronic wound pathogenic biofilms are host-
pathogen co-exist environments that many bacterial species cohabitate to promote their 
own survival.  Many people have the misconception that systemic antibiotics alone can 
treat these infections. However, the truth is that use of antibiotics alone is often harmful, 
because they often breed bacteria that are resistant to the antibiotic being used.  For 
that reason, photodynamic antimicrobial chemotherapy (PACT) has the potential to 
represent an alternative antibacterial, antifungal, and antiviral treatment for drug-
resistant microorganisms. It is very unlikely for any organisms to develop resistance to 
cytotoxic reactive molecules such as reactive oxygen species (ROS) generated by the 
photosensitizers. Our studies have shown that non-toxic vitamins such as riboflavin 
(vitamin B6),  phylloquinone (vitamin K1), and menaquinone (vitamin K2) are excellent 
photosensitizes that can produce singlet oxygen and free radicals upon irradiation.  We 
have also developed a unique nano-emulsion to increase the solubility of these 
otherwise hard to dissolve, hydrophobic vitamins for faster, more effective delivery to 
the target cells. This invention will provide a novel photodynamic chemotherapeutic 
regime for the treatment of chronic wound ulcers caused by microbial biofilms.  
 Photodynamic therapy (PDT) is a technique that uses the combination of light 
and nontoxic drugs to destroy specific targeted cells.1-11 After the inactive and nontoxic 
drug is applied topically or injected, it localizes in the selected tissue and can only be 
activated by irradiation with certain wavelengths of light. When these photosensitive 
drugs are activated, they can produce highly reactive intermediates and ultimately lead 
to the selective death of targeted cells without affecting normal tissue.  Currently, PDT is 
being applied mostly in the treatment of cancer.2,4,6,8,9 However, several studies have 
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shown that PDT can also be utilized in antimicrobial management.1,4,5,7 Research 
interest in antimicrobial PDT diminished for many years due to the availability of 
antibiotics. However, in recent years, the emergence of antibiotic-resistant bacterial 
strains, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant 
Enterococcus faecalis, has renewed interest in alternative treatments.  
   It has been established that there are specific major populations of bacteria that 
are habited in all chronic wound biofilms. Species including Staphylococcus, 
Pseudomonas, Peptoniphilus, Enterobacter, Stenotrophomonas, Finegoldia, and 
Serratia spp are found to be common chronic wound pathogens.12 Bacterial biofilms are 
highly organized microbial communities living within a protective extracellular matrix. 
They are difficult to detect and highly resistant to immune or antibiotic elimination. It has 
been suggested that biofilm presence may contribute to the intractable inflammatory 
processes seen in chronic wounds. Several clinical studies showed there was a 
statistically significant (p<0.001) that chronic wound patients had developed biofilms (> 
60%) verses that of acute wound patients (6%). Molecular analyses of chronic wound 
specimens have revealed the diverse polymicrobial communities and the presence of 
bacterial colonization.13-15 
 Various metallic compounds have been investigated for their utility as PDT 
agents, most notably cisplatin in the treatment of cancer.16 The primary problems with 
cisplatin are its selective utility against various forms of cancer, its toxicity to human 
cells, and the resistance that tumor cells may develop against it.16 Other metallic 
compounds have been thoroughly investigated for their photoreactive properties and 
their utility as PDT agents and, more specifically, PACT agents.17-25 While many suffer 
from the same shortcomings as cisplatin, some do not have the same side effects; 
however, all the metallic compounds suffer from problems related to synthesis.  That is, 
they have complex syntheses and may be costly to manufacture.  Naturally occurring 
compounds such as riboflavin and phylloquinone do not have the drawbacks associated 
with synthesis.  Naturally occurring compounds have the added benefit that they will not 
harm normal tissue.  That is, they remain inert until photoactivated, thus, they are great 
candidates for PACT agents. 
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 Our research would eventually solve many of the major problems associated with 
post-wound infections by developing a new, fully characterized treatment that is based 
on well-known, inexpensive, and innocuous aqueous vitamin nanoparticles in 
combination with light therapy.  
 
Methods  
DNA Photocleavage 
The DNA photocleavage experiments were carried out on a 20 µL total sample volume 
in 0.5 mL transparent Eppendorf microtubes containing 120 µM pUC19 plasmid and 30 
µM of DAP in 10 mM phosphate buffer, 5 mM NaCl, pH = 7.5. All samples were 
irradiated for 30 min after 30 minutes of incubation following addition of DAP.  After 
irradiation, the samples were loaded into the gel following the addition of 4 µL of DNA 
gel loading solution to each reaction mixture. In showing the pH dependence of 
photocleavage, the pH of each reaction mixture was varied using phosphate buffer 
before adding DAP and irradiation. All the photolysis experiments were conducted in air 
at room temperature.  The electrophoresis was carried out using 2% agarose gel 
stained with 0.5 mg/L ethidium bromide in 1X TAE running buffer (TAE = tris-acetate 
EDTA) at 90 V for 1.5 hours, and the gels were imaged on a GelDoc 2000 
transilluminator (Bio-Rad, Hercules, CA).  The extent of photocleavage was calculated 
from the ratio of nicked (circular) to supercoiled ds-DNA determined from the integration 
of image intensity available in the QuantityOne Analysis System software (Bio-Rad, 
Hercules, CA). In these measurements, no correction was made for the difference in 
EtBr emission from the different forms of DNA.   
 
Cytotoxicity and Photocytotoxicity Assays.   
Human skin fibroblasts (Hs-27) were obtained from the American Type Culture 
Collection, cell line CRL-1634 (Manassas, VA).  The cells were cultured in Dulbecco’s 
Modified Eagle Media, containing 10% fetal bovine serum, 50 µg/mL gentamicin, 4.5 
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mg/mL glucose, and 4 mM L-glutamine.   The cell cultures were incubated in a 
humidified atmosphere containing 5% CO2 at 37 oC. 
 For assessing the cytotoxicity and photocytotoxicity of nanoparticles, >80% 
confluent monolayers of Hs-27 in 60 mm culture dishes were used.  The monolayers 
were first washed twice with phosphate-buffered saline (PBS) to ensure that the culture 
dishes were free of any culture medium.  Fresh PBS (3 mL) containing various 
concentrations of DAP was then added to cover the fibroblasts.  The cells were 
irradiated through the PBS buffer, which does not absorb light in the visible region, 
immediately without an incubation period.  The spectral output of the visible light was 
~2.8 x 10–3 W/cm2, and all samples were irradiated no longer than 30 min (~5 J/cm2) 
at room temperature.  Following irradiation, the cells were removed from the dishes by 
trypsinization, reseeded into 24-well culture dishes, and incubated for 48 hours.  N-
lauroyl sarcosine (200 µL, 40 mM) was then added to each well and the cells were 
allowed to lyse for at least 30 min.  Quantitative determination of the protein content in 
each well was undertaken using Peterson's modification of the micro-Lowry method.  
The lysate was treated with 200 µL Lowry reagent for 30 min and then with 100 µL 
Folin-Ciocalteau phenol reagent for 30 min. A portion (200 µL) of the contents of each 
well was transferred to a 96-well plate for absorbance determination using a 96 well 
MRX plate reader (Dynatech Laboratory, DynPort, VA).  The absorbance measured at 
630 nm is proportional to the total protein content and the number of cells in each well.  
Nanoemulsion: 
 Due to most photoactive vitamins in nature being either hydrophobic or low in 
solubility, we have developed a biocompatible nano-emulsion in order to deliver 
lipophilic vitamins to target cells more effectively. We used high a HLB (hydrophilic-
lipophilic balance) emulsifier to prepare our oil in water nanoparticles. Tween 20 has a 
HLB of 16.7 which serves as the emulsifier. We use vitamin F (mixture of linoleic acid 
and alpha linoleic acid) as our primary fatty acid which has a HLB of 14-15. It meets the 
criteria of HLB for solubilizing oil in water to make clear nanoemulsion. HLB value needs 
to be in between13-18.  
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Making Emulsion: 
Oil                                                               16% 
Emulsifier                                       4% 
Water                                        80% 
Primary Emulsion: 
Vitamin F with vitamin                             4 Parts 
Water                                             2 Parts 
Tween 20 (Emulsifier)                              1 Part 
 Hydrophobic vitamin was dissolved in fatty acid (vitamin F) by vortexing in a 
centrifuge tube.  Then one part of Tween 20 and 2 parts (v/v) of water were added to it 
and vortexed for 5 min. This primary emulsion was sonicated for 1 hour in Brason 2500 
sonifier. This primary emulsion was diluted 1:10 to avoid aggregation and Tween 20 
was added drop by drop to make clear emulsion. It was again sonicated for additional 
30 minutes to reduce the particle size and get a clear emulsion. 
 
Results 
 Our data has shown that riboflavin not only has an excellent DNA binding 
constant (Kb > 104 M-1). Shown in Figure 1, it can also cleave DNA under  irradiation 
with visible light (λ > 395 nm). A singlet oxygen study using  9,10-anthracene 
dipropinoic acid (ADPA) as the singlet oxygen sensor has shown that riboflavin is 
capable of producing a large quantity of singlet oxygen after only 15 minutes of  
irradiation (Figure2).   
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Figure 2: 
  
Figure 3: TEM image of vitamin K encapsulated nanoparticles.  
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Figure4: Riboflavin solubility increased more than 3 fold by using nanoemulsion. 
Picture on the left shows riboflavin precipitation in water at 250 µM, picture on the right 
shows clear solution at 750 µM.  
 
 
 
 
 
  
 
 Antibacterial study has shown that after one hour incubation and 30 minutes 
irradiation with low intensity light (about 5J/cm2), a concentration of riboflavin as low as 
85 mg/Kg can cause 50% bacteria fatality. Compare with the acute oral toxicity 
recorded on the official MSDS of LD50 > 10g/Kg. Therefore, needless to say, the 
concentration used for eradicating bacteria would have no effect to the normal human 
cells. The same result was also obtained in the phylloquinone study.  Table 1 shows the 
complete summary of our bacterial study with LD50 values in mg/Kg.  
Table 1:  LD50 (lethal dose 50 in mg/Kg) of riboflavin and phylloquinone in both 
irradiated and dark conditions. Acute oral systematic toxicity of both was cited 
from the official MSDS.  
     Human  Skin               E  coli Acute Oral 
Toxicity 
    Dark Irradiated   Dark Irradiated  
Riboflavin No Effect   2,100     197        85 > 10,000 
Phylloquinone No Effect 18,779   1,100       423            25,000 
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Conclusion 
Our research will provide significant improvement to heal chronic wounds by 
using non-expensive, non-toxic photoactive vitamin nanoparticles as new photodynamic 
antimicrobial chemotherapeutic agents. The expense in lost manpower, hospitalizations, 
debilitation, and even death is costly globally. Conventional methods of killing bacteria 
(such as antibiotics and disinfection) are often ineffective due to increasing rates of 
multidrug resistance and can cause additional damage to surrounding tissue, thus 
inhibiting recovery and overall successful surgical outcomes. The huge doses of 
antimicrobials required to treat patients who are already immunosuppressed are 
medically undesirable, and are increasingly ineffective.  As a result, new strategies are 
urgently needed for immediate use and PACT has proven to be the solution.  In 
addition, spin-off applications of this work would offer opportunities for other 
environmental friendly uses such as bioremediating hazardous waste sites, biofiltering 
industrial water, and forming biobarriers to protect soil and groundwater from 
contamination  
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